Literature DB >> 15539528

Biased immunoglobulin G (IgG) subclass production in a case of hyper-IgM syndrome.

G R McLean1, K K Miller, J W Schrader, A K Junker.   

Abstract

Hyper-immunoglobulin M (IgM) syndrome (HIGM) is a rare heterogeneous primary immune deficiency. We describe a patient with HIGM characterized by skewed production of serum IgG subclasses and normal somatic hypermutation. This case may represent a subgroup of HIGM type 4 that is characterized by a biased switching to the V-region proximal constant regions.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15539528      PMCID： PMC524785          DOI： 10.1128/CDLI.11.6.1192-1193.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  12 in total

1.  Non-functional immunoglobulin G transcripts in a case of hyper-immunoglobulin M syndrome similar to type 4.

Authors:  John M Darlow; Alex M Farrell; David I Stott
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

2.  Serum IgG subclass levels in patients with primary immunodeficiency syndromes or abnormal susceptibility to infections.

Authors:  P Aucouturier; C Lacombe; C Bremard; Y Lebranchu; M Seligmann; C Griscelli; J L Preud'Homme
Journal:  Clin Immunol Immunopathol       Date:  1989-04

Review 3.  Somatic hypermutation of immunoglobulin genes.

Authors:  S D Wagner; M S Neuberger
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

4.  Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia.

Authors:  A Jain; C A Ma; S Liu; M Brown; J Cohen; W Strober
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

5.  Development of hypogammaglobulinaemia in a patient with common variable immunodeficiency.

Authors:  A Ishizaka; M Nakanishi; S Yamada; Y Sakiyama; S Matsumoto
Journal:  Eur J Pediatr       Date:  1989-12       Impact factor: 3.183

6.  B cell differentiation and lymphocyte surface phenotype in late onset hypogammaglobulinaemia.

Authors:  M F Duggan-Keen; A G Bird; P Bird; S W Smith; A L Givan; J E Calvert
Journal:  Dis Markers       Date:  1990 Mar-Apr       Impact factor: 3.434

7.  Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM.

Authors:  S Ferrari; S Giliani; A Insalaco; A Al-Ghonaium; A R Soresina; M Loubser; M A Avanzini; M Marconi; R Badolato; A G Ugazio; Y Levy; N Catalan; A Durandy; A Tbakhi; L D Notarangelo; A Plebani
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

8.  Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination.

Authors:  Kohsuke Imai; Nadia Catalan; Alessandro Plebani; László Maródi; Ozden Sanal; Satoru Kumaki; Vasantha Nagendran; Philip Wood; Catherine Glastre; Françoise Sarrot-Reynauld; Olivier Hermine; Monique Forveille; Patrick Revy; Alain Fischer; Anne Durandy
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

9.  Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination.

Authors:  Kohsuke Imai; Geir Slupphaug; Wen-I Lee; Patrick Revy; Shigeaki Nonoyama; Nadia Catalan; Leman Yel; Monique Forveille; Bodil Kavli; Hans E Krokan; Hans D Ochs; Alain Fischer; Anne Durandy
Journal:  Nat Immunol       Date:  2003-09-07       Impact factor: 25.606

10.  Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

Authors:  P Revy; T Muto; Y Levy; F Geissmann; A Plebani; O Sanal; N Catalan; M Forveille; R Dufourcq-Labelouse; A Gennery; I Tezcan; F Ersoy; H Kayserili; A G Ugazio; N Brousse; M Muramatsu; L D Notarangelo; K Kinoshita; T Honjo; A Fischer; A Durandy
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582
View more
  1 in total

1.  CD40 Ligand Deficient C57BL/6 Mouse Is a Potential Surrogate Model of Human X-Linked Hyper IgM (X-HIGM) Syndrome for Characterizing Immune Responses against Pathogens.

Authors:  Catalina Lopez-Saucedo; Rodolfo Bernal-Reynaga; Jesus Zayas-Jahuey; Silvia Galindo-Gomez; Mineko Shibayama; Carlos Garcia-Galvez; Sergio Estrada-Parra; Teresa Estrada-Garcia
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.